Ad is loading...
CBDRX
Price
$54.85
Change
-$0.52 (-0.94%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

CBDRX vs RLEFX

Header iconCBDRX vs RLEFX Comparison
Open Charts CBDRX vs RLEFXBanner chart's image
Columbia Balanced Adv
Price$54.85
Change-$0.52 (-0.94%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
CBDRX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBDRX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBDRX is a StrongSell and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. CBDRX (9.72B). RLEFX pays higher dividends than CBDRX: RLEFX (2.42) vs CBDRX (1.90). CBDRX was incepted earlier than RLEFX: CBDRX (12 years) vs RLEFX (9 years). CBDRX (171.00) and RLEFX (171.00) have comparable annual turnover. RLEFX has a lower initial minimum investment than CBDRX: RLEFX (250) vs CBDRX (2000). RLEFX (21.09) and CBDRX (20.91) have marching annual gain over last year. RLEFX return over 5 years is better than : 35.95 vs. CBDRX (31.99).
CBDRXRLEFXCBDRX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years9 years-
Gain YTD14.16114.211100%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets9.72B236B4%
Annual Yield % from dividends1.902.4279%
Returns for 1 year20.9121.0999%
Returns for 3 years3.4110.9531%
Returns for 5 years31.9935.9589%
Returns for 10 years58.72N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology